Acute Pancreatitis
Gastroenterology·MeSH: Pancreatitis
Prevalence
79.6 / 100K
Incidence
37.0 / 100K/yr
7 drugs in development·6 companies·4 clinical trials
Drug Pipeline by Phase
Phase 2(3)
Preclinical(2)
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| cm4620 | GH Research PLC (GHRS) |
Phase 2/Phase 3(1)
| Drug | Company |
|---|---|
| dm300 | DiaMedica Therapeutics Inc. (DMAC) |
Compare drugs
Frequently asked questions
How many drugs are in development for Acute Pancreatitis?
BioSniper tracks 7 drugs in development for Acute Pancreatitis across 6 companies.
How many clinical trials target Acute Pancreatitis?
There are 4 clinical trials targeting Acute Pancreatitis tracked by BioSniper.
What is the prevalence of Acute Pancreatitis?
The estimated prevalence of Acute Pancreatitis is approximately 79.6 per 100,000 population.
Deep-dive into Acute Pancreatitis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis